Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

NCT01545947

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars Sinai Medical Center, Inflammatory Bowel Disease Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • NYU School of Medicine New York, United States
  • Cancer Center of the Carolinas Greenville, South Carolina, United States
View Trial Details
Completed

Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

NCT03137264

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site St. Helena, California, United States
View all 23 locations
View Trial Details
Completed

A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer

NCT02000947

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 69 locations
View Trial Details
Completed

Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

NCT02604342

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GHdC Site Notre Dame Charleroi, Belgium
  • UZ Antwerpen Edegem, Belgium
  • UZ Gent Ghent, Belgium
  • MBAL Serdika EOOD Sofia, Bulgaria
View all 54 locations
View Trial Details
Completed

Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02944396

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Alabama at Birmingham - Main /ID# 155135 Birmingham, Alabama, United States
  • Icri /Id# 155593 Whittier, California, United States
  • Univ of Colorado Cancer Center /ID# 153820 Aurora, Colorado, United States
  • University of Chicago /ID# 153824 Chicago, Illinois, United States
View Trial Details

Related conditions